Katie Haubrich

Overview: Dr. Katie Haubrich's research areas include medication use and dosing in children with chronic kidney disease and on dialysis, immunosuppressant pharmacokinetics (how your body deals with the immune-suppressing drugs you need after a transplant), and monitoring for adverse effects of medications in transplant recipients. She is also interested in how pharmacists and health care teams communicate information about medications and treatments to families.
Publications: Mycobacterium fortuitum peritoneal dialysis-related peritonitis in a child: A case report and review of the literature
Official Journal of the Association of Medical Microbiology and Infectious Disease Canada
Kathryn Haubrich and Cherry Mammen and Inna Sekirov and Hana Mitchell
DOI: 10.3138/jammi-2021-0029
06/2022
Valganciclovir prophylaxis delays onset of EBV viremia in high-risk pediatric solid organ transplant recipients
Pediatric Research
DOI: 10.1038/s41390-019-0523-4
04/2020
RELATE: Relationship of limited sampling strategy and adverse effects of mycophenolate mofetil in pediatric renal transplant patients
Pediatric Transplantation
Iona Berger and Kathryn Haubrich and Mary H. H. Ensom and Roxane Carr
DOI: 10.1111/petr.13355
03/2019
Successful treatment of chronic norovirus gastroenteritis with nitazoxanide in a pediatric kidney transplant recipient
Pediatric Transplantation
Kathryn Haubrich and Soren Gantt and Tom Blydt-Hansen
DOI: 10.1111/petr.13186
06/2018
Research: Correlation of limited sampling strategy for mycophenolate in pediatric solid organ transplant patients
Mycophenolate is commonly used as an immunosuppressant in children who have received solid organ transplants to prevent rejection of the graft. Currently therapeutic drug monitoring is recommended as dosage and serum concentration do not correlate well however it is unclear from the literature what the upper limit of the therapeutic range should be and if limited sampling strategies to estimate area under the curve correlates to effectiveness and adverse drug reactions. Objective: To describe the correlation between limited sampling strategy for mycophenolate and clinical effectiveness (adverse drug reactions and signs or organ graft rejection).
Recombinant Growth Hormone Treatment in Children with Chronic Kidney Disease
Recombinant human growth hormone (rhGH) has been shown to support linear growth in children with chronic kidney disease. However, optimal dosing and duration of therapy remains poorly described. Objective: to describe the effectiveness of rhGH therapy on height velocity and height standard deviation score, stratifying by primary renal disease, and the incidence of adverse effects in children managed on rhGH therapy.

Stories See all

Torin Halvorson and Hebah Hussaina awarded Vanier scholarships for immunotherapy and mental health research

BC Children’s Hospital Research Institute (BCCHR) is proud to announce that two of its outstanding research trainees, Torin Halvorson, an MD/PhD student working with the Levings research team, and Hebah Hussaina, a graduate research assistant in the Brussoni Lab, have been awarded the prestigious 2024 Vanier Canada Graduate Scholarship.

Continue reading Torin Halvorson and Hebah Hussaina awarded Vanier scholarships for immunotherapy and mental health research

Studies highlight the impact of the pandemic on children and youth’s mental health

The Pediatric Outcome ImProvement through COordination of Research Networks — which involves BCCHR — has published their latest research findings on mental health hospitalizations of children and youth throughout the pandemic. These findings led the team to a second study where they evaluated the relationship between hospital admissions for eating disorders and public health restrictions.

Continue reading Studies highlight the impact of the pandemic on children and youth’s mental health

Recognizing a brain injury quickly can save lives

Knowing how to recognize brain injury as early as possible and what to do is crucial to reduce potential long-term complications. Mild traumatic brain injuries are more prevalent in children and youth than adults, often as a result of sport- and recreation-related events.

Continue reading Recognizing a brain injury quickly can save lives

A decade of work advances care for children with cancer

Researchers at the Michael Cuccione Childhood Cancer Research Program at BC Children’s Hospital Research Institute have been working for over a decade on the BC Pediatric Personalized OncoGenomics (PedsPOG) study, using genomics to identify treatments specific to an individual child’s cancer.

Continue reading A decade of work advances care for children with cancer

BC Children’s Hospital Research Institute brings Mini Science Night to Salmon Arm

Scheduled for May 2, in Salmon Arm, BC, Mini Science Night is a public lecture that explores the newest discoveries and innovations in health research. Admission is free and everyone in the community is welcome to attend, including students, teachers, parents, seniors, and local health-care professionals. There are 50 seats available to the public when registration opens on April 2.

Continue reading BC Children’s Hospital Research Institute brings Mini Science Night to Salmon Arm

Donate to Research

We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.

Give Now